Search Results for: Influenza

856 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
GATA3 and HDAC1 GATA binding protein 3 histone deacetylase 1
  • Ub-specific processing proteases
  • Interleukin-4 and Interleukin-13 signaling
  • RUNX1 regulates transcription of genes involved in differentiation of HSCs
  • Estrogen-dependent gene expression
  • Factors involved in megakaryocyte development and platelet production
  • Transcription of E2F targets under negative control by DREAM complex
  • Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1
  • G0 and Early G1
  • p75NTR negatively regulates cell cycle via SC1
  • Formation of the beta-catenin:TCF transactivating complex
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • HDACs deacetylate histones
  • Notch-HLH transcription pathway
  • Deactivation of the beta-catenin transactivating complex
  • ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression
  • NoRC negatively regulates rRNA expression
  • SUMOylation of chromatin organization proteins
  • Repression of WNT target genes
  • Repression of WNT target genes
  • Regulation of TP53 Activity through Acetylation
  • G1/S-Specific Transcription
  • RNA Polymerase I Transcription Initiation
  • RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
  • Regulation of PTEN gene transcription
  • Regulation of PTEN gene transcription
  • Estrogen-dependent gene expression
  • Loss of MECP2 binding ability to 5mC-DNA
  • Regulation of MECP2 expression and activity
  • MECP2 regulates neuronal receptors and channels
  • MECP2 regulates transcription of neuronal ligands
  • FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
  • Factors involved in megakaryocyte development and platelet production
  • Arsenic trioxide
  • Zinc
  • Vorinostat
  • Belinostat
  • Pracinostat
  • Romidepsin
  • Panobinostat
  • Fingolimod
  • Mocetinostat
  • Abexinostat
GATA3 and FBXW7 GATA binding protein 3 F-box and WD repeat domain containing 7
  • Ub-specific processing proteases
  • Interleukin-4 and Interleukin-13 signaling
  • RUNX1 regulates transcription of genes involved in differentiation of HSCs
  • Estrogen-dependent gene expression
  • Factors involved in megakaryocyte development and platelet production
  • Association of TriC/CCT with target proteins during biosynthesis
  • Neddylation
  • Antigen processing: Ubiquitination & Proteasome degradation
B4GALT1 and CDK11A beta-1,4-galactosyltransferase 1 cyclin dependent kinase 11A
  • Pre-NOTCH Processing in Golgi
  • Keratan sulfate biosynthesis
  • Interaction With Cumulus Cells And The Zona Pellucida
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Lactose synthesis
  • Neutrophil degranulation
  • N-Glycan antennae elongation
  • Recruitment of mitotic centrosome proteins and complexes
  • N-Acetylglucosamine
  • 6-Aminohexyl-Uridine-C1,5'-Diphosphate
  • Di(N-Acetyl-D-Glucosamine)
  • Galactose-uridine-5'-diphosphate
  • Uridine monophosphate
  • 2-(N-Morpholino)-Ethanesulfonic Acid
  • Congenital disorders of glycosylation (CDG) type II
B4GALT1 and TUBA1A beta-1,4-galactosyltransferase 1 tubulin alpha 1a
  • Pre-NOTCH Processing in Golgi
  • Keratan sulfate biosynthesis
  • Interaction With Cumulus Cells And The Zona Pellucida
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Lactose synthesis
  • Neutrophil degranulation
  • N-Glycan antennae elongation
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane
  • Gap junction assembly
  • MHC class II antigen presentation
  • Separation of Sister Chromatids
  • Resolution of Sister Chromatid Cohesion
  • Regulation of PLK1 Activity at G2/M Transition
  • HSP90 chaperone cycle for steroid hormone receptors (SHR)
  • Loss of Nlp from mitotic centrosomes
  • Recruitment of mitotic centrosome proteins and complexes
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Recruitment of NuMA to mitotic centrosomes
  • Prefoldin mediated transfer of substrate to CCT/TriC
  • Formation of tubulin folding intermediates by CCT/TriC
  • Post-chaperonin tubulin folding pathway
  • Recycling pathway of L1
  • Recycling pathway of L1
  • Hedgehog 'off' state
  • Cilium Assembly
  • Anchoring of the basal body to the plasma membrane
  • Intraflagellar transport
  • RHO GTPases activate IQGAPs
  • RHO GTPases Activate Formins
  • COPI-mediated anterograde transport
  • COPI-dependent Golgi-to-ER retrograde traffic
  • COPI-independent Golgi-to-ER retrograde traffic
  • Mitotic Prometaphase
  • The role of GTSE1 in G2/M progression after G2 checkpoint
  • AURKA Activation by TPX2
  • Carboxyterminal post-translational modifications of tubulin
  • Carboxyterminal post-translational modifications of tubulin
  • HCMV Early Events
  • Assembly and cell surface presentation of NMDA receptors
  • Activation of AMPK downstream of NMDARs
  • Aggrephagy
  • Aggrephagy
  • EML4 and NUDC in mitotic spindle formation
  • Sealing of the nuclear envelope (NE) by ESCRT-III
  • Kinesins
  • N-Acetylglucosamine
  • 6-Aminohexyl-Uridine-C1,5'-Diphosphate
  • Di(N-Acetyl-D-Glucosamine)
  • Galactose-uridine-5'-diphosphate
  • Uridine monophosphate
  • 2-(N-Morpholino)-Ethanesulfonic Acid
  • Albendazole
  • Vinblastine
  • Mebendazole
  • Epothilone D
  • Patupilone
  • CYT997
  • 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE
  • Artenimol
  • Phenethyl Isothiocyanate
  • Congenital disorders of glycosylation (CDG) type II
  • Lissencephaly (LIS); Miller-Dieker syndrome (MDLS)
B4GALT1 and TUBB beta-1,4-galactosyltransferase 1 tubulin beta class I
  • Pre-NOTCH Processing in Golgi
  • Keratan sulfate biosynthesis
  • Interaction With Cumulus Cells And The Zona Pellucida
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Lactose synthesis
  • Neutrophil degranulation
  • N-Glycan antennae elongation
  • Regulation of PLK1 Activity at G2/M Transition
  • Loss of Nlp from mitotic centrosomes
  • Recruitment of mitotic centrosome proteins and complexes
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Recruitment of NuMA to mitotic centrosomes
  • Anchoring of the basal body to the plasma membrane
  • Neutrophil degranulation
  • AURKA Activation by TPX2
  • N-Acetylglucosamine
  • 6-Aminohexyl-Uridine-C1,5'-Diphosphate
  • Di(N-Acetyl-D-Glucosamine)
  • Galactose-uridine-5'-diphosphate
  • Uridine monophosphate
  • 2-(N-Morpholino)-Ethanesulfonic Acid
  • Vinorelbine
  • Vincristine
  • Vinblastine
  • Podofilox
  • Colchicine
  • Epothilone D
  • Patupilone
  • CYT997
  • CA4P
  • ZEN-012
  • Copper
  • Depatuxizumab mafodotin
  • Milataxel
  • Congenital disorders of glycosylation (CDG) type II
B4GALT1 and LALBA beta-1,4-galactosyltransferase 1 lactalbumin alpha
  • Pre-NOTCH Processing in Golgi
  • Keratan sulfate biosynthesis
  • Interaction With Cumulus Cells And The Zona Pellucida
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Lactose synthesis
  • Neutrophil degranulation
  • N-Glycan antennae elongation
  • Lactose synthesis
  • N-Acetylglucosamine
  • 6-Aminohexyl-Uridine-C1,5'-Diphosphate
  • Di(N-Acetyl-D-Glucosamine)
  • Galactose-uridine-5'-diphosphate
  • Uridine monophosphate
  • 2-(N-Morpholino)-Ethanesulfonic Acid
  • Palmitic Acid
  • Congenital disorders of glycosylation (CDG) type II
B4GALT1 and TUBA4A beta-1,4-galactosyltransferase 1 tubulin alpha 4a
  • Pre-NOTCH Processing in Golgi
  • Keratan sulfate biosynthesis
  • Interaction With Cumulus Cells And The Zona Pellucida
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Lactose synthesis
  • Neutrophil degranulation
  • N-Glycan antennae elongation
  • Platelet degranulation
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane
  • Gap junction assembly
  • MHC class II antigen presentation
  • Separation of Sister Chromatids
  • Resolution of Sister Chromatid Cohesion
  • Regulation of PLK1 Activity at G2/M Transition
  • HSP90 chaperone cycle for steroid hormone receptors (SHR)
  • Loss of Nlp from mitotic centrosomes
  • Recruitment of mitotic centrosome proteins and complexes
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Recruitment of NuMA to mitotic centrosomes
  • Prefoldin mediated transfer of substrate to CCT/TriC
  • Formation of tubulin folding intermediates by CCT/TriC
  • Post-chaperonin tubulin folding pathway
  • Recycling pathway of L1
  • Recycling pathway of L1
  • Hedgehog 'off' state
  • Cilium Assembly
  • Anchoring of the basal body to the plasma membrane
  • Intraflagellar transport
  • RHO GTPases activate IQGAPs
  • RHO GTPases Activate Formins
  • COPI-mediated anterograde transport
  • COPI-dependent Golgi-to-ER retrograde traffic
  • COPI-independent Golgi-to-ER retrograde traffic
  • Mitotic Prometaphase
  • The role of GTSE1 in G2/M progression after G2 checkpoint
  • AURKA Activation by TPX2
  • Carboxyterminal post-translational modifications of tubulin
  • Carboxyterminal post-translational modifications of tubulin
  • HCMV Early Events
  • Assembly and cell surface presentation of NMDA receptors
  • Activation of AMPK downstream of NMDARs
  • Aggrephagy
  • Aggrephagy
  • EML4 and NUDC in mitotic spindle formation
  • Sealing of the nuclear envelope (NE) by ESCRT-III
  • Kinesins
  • N-Acetylglucosamine
  • 6-Aminohexyl-Uridine-C1,5'-Diphosphate
  • Di(N-Acetyl-D-Glucosamine)
  • Galactose-uridine-5'-diphosphate
  • Uridine monophosphate
  • 2-(N-Morpholino)-Ethanesulfonic Acid
  • Vincristine
  • Podofilox
  • Epothilone D
  • Patupilone
  • CYT997
  • S-8184
  • Cabazitaxel
  • Phenethyl Isothiocyanate
  • Congenital disorders of glycosylation (CDG) type II
B4GALT1 and TFRC beta-1,4-galactosyltransferase 1 transferrin receptor
  • Pre-NOTCH Processing in Golgi
  • Keratan sulfate biosynthesis
  • Interaction With Cumulus Cells And The Zona Pellucida
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Lactose synthesis
  • Neutrophil degranulation
  • N-Glycan antennae elongation
  • Golgi Associated Vesicle Biogenesis
  • Cargo recognition for clathrin-mediated endocytosis
  • Clathrin-mediated endocytosis
  • Transferrin endocytosis and recycling
  • N-Acetylglucosamine
  • 6-Aminohexyl-Uridine-C1,5'-Diphosphate
  • Di(N-Acetyl-D-Glucosamine)
  • Galactose-uridine-5'-diphosphate
  • Uridine monophosphate
  • 2-(N-Morpholino)-Ethanesulfonic Acid
  • Iron
  • Congenital disorders of glycosylation (CDG) type II
GLP1R and TMCO3 glucagon like peptide 1 receptor transmembrane and coiled-coil domains 3
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • G alpha (s) signalling events
  • Glucagon-type ligand receptors
  • ADORA2B mediated anti-inflammatory cytokines production
  • Glucagon recombinant
  • Exenatide
  • Liraglutide
  • Albiglutide
  • Dulaglutide
  • Lixisenatide
  • Semaglutide
GNAI1 and NUMA1 G protein subunit alpha i1 nuclear mitotic apparatus protein 1
  • PLC beta mediated events
  • PLC beta mediated events
  • Adenylate cyclase inhibitory pathway
  • Adenylate cyclase inhibitory pathway
  • G-protein activation
  • ADP signalling through P2Y purinoceptor 12
  • Adrenaline,noradrenaline inhibits insulin secretion
  • Adrenaline,noradrenaline inhibits insulin secretion
  • G alpha (s) signalling events
  • G alpha (i) signalling events
  • G alpha (i) signalling events
  • G alpha (z) signalling events
  • Regulation of insulin secretion
  • Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
  • Extra-nuclear estrogen signaling
  • ADORA2B mediated anti-inflammatory cytokines production
  • Recruitment of NuMA to mitotic centrosomes
  • Mitotic Prophase
  • Guanosine-5'-Diphosphate
  • Tetrafluoroaluminate Ion
GNAQ and RIC8B G protein subunit alpha q RIC8 guanine nucleotide exchange factor B
  • Acetylcholine regulates insulin secretion
  • Acetylcholine regulates insulin secretion
  • G alpha (q) signalling events
  • G alpha (q) signalling events
  • ADP signalling through P2Y purinoceptor 1
  • ADP signalling through P2Y purinoceptor 1
  • Thromboxane signalling through TP receptor
  • Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion
  • Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion
  • Thrombin signalling through proteinase activated receptors (PARs)
GNAS and RIC8B GNAS complex locus RIC8 guanine nucleotide exchange factor B
  • Glucagon signaling in metabolic regulation
  • PKA activation in glucagon signalling
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • Prostacyclin signalling through prostacyclin receptor
  • Prostacyclin signalling through prostacyclin receptor
  • G alpha (s) signalling events
  • G alpha (s) signalling events
  • G alpha (i) signalling events
  • G alpha (z) signalling events
  • Glucagon-type ligand receptors
  • Vasopressin regulates renal water homeostasis via Aquaporins
  • Hedgehog 'off' state
  • ADORA2B mediated anti-inflammatory cytokines production
  • ADORA2B mediated anti-inflammatory cytokines production
  • Glucagon signaling in metabolic regulation
  • PKA activation in glucagon signalling
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • Prostacyclin signalling through prostacyclin receptor
  • Prostacyclin signalling through prostacyclin receptor
  • G alpha (s) signalling events
  • G alpha (s) signalling events
  • G alpha (i) signalling events
  • G alpha (z) signalling events
  • Glucagon-type ligand receptors
  • Vasopressin regulates renal water homeostasis via Aquaporins
  • Hedgehog 'off' state
  • ADORA2B mediated anti-inflammatory cytokines production
  • ADORA2B mediated anti-inflammatory cytokines production
  • Colforsin
  • 2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE
  • Fibrous dysplasia, polyostotic; Albright hereditary osteodystrophy
  • Pseudohypoparathyroidism
  • Progressive osseous heteroplasia (POH)
GNAS and SNX13 GNAS complex locus sorting nexin 13
  • Glucagon signaling in metabolic regulation
  • PKA activation in glucagon signalling
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • Prostacyclin signalling through prostacyclin receptor
  • Prostacyclin signalling through prostacyclin receptor
  • G alpha (s) signalling events
  • G alpha (s) signalling events
  • G alpha (i) signalling events
  • G alpha (z) signalling events
  • Glucagon-type ligand receptors
  • Vasopressin regulates renal water homeostasis via Aquaporins
  • Hedgehog 'off' state
  • ADORA2B mediated anti-inflammatory cytokines production
  • ADORA2B mediated anti-inflammatory cytokines production
  • Glucagon signaling in metabolic regulation
  • PKA activation in glucagon signalling
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • Prostacyclin signalling through prostacyclin receptor
  • Prostacyclin signalling through prostacyclin receptor
  • G alpha (s) signalling events
  • G alpha (s) signalling events
  • G alpha (i) signalling events
  • G alpha (z) signalling events
  • Glucagon-type ligand receptors
  • Vasopressin regulates renal water homeostasis via Aquaporins
  • Hedgehog 'off' state
  • ADORA2B mediated anti-inflammatory cytokines production
  • ADORA2B mediated anti-inflammatory cytokines production
  • Colforsin
  • 2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE
  • Fibrous dysplasia, polyostotic; Albright hereditary osteodystrophy
  • Pseudohypoparathyroidism
  • Progressive osseous heteroplasia (POH)
GPR25 and NAALADL2 G protein-coupled receptor 25 N-acetylated alpha-linked acidic dipeptidase like 2
  • G alpha (s) signalling events
  • ADORA2B mediated anti-inflammatory cytokines production
GRB2 and PDCD6IP growth factor receptor bound protein 2 programmed cell death 6 interacting protein
  • Interleukin-15 signaling
  • Interleukin-15 signaling
  • Budding and maturation of HIV virion
  • Uptake and function of anthrax toxins
  • Pegademase bovine
  • 4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid
GRB2 and ADAM12 growth factor receptor bound protein 2 ADAM metallopeptidase domain 12
  • Interleukin-15 signaling
  • Interleukin-15 signaling
  • Signaling by EGFR
  • Invadopodia formation
  • Pegademase bovine
  • 4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid
GRM2 and NAALADL2 glutamate metabotropic receptor 2 N-acetylated alpha-linked acidic dipeptidase like 2
  • G alpha (i) signalling events
  • Class C/3 (Metabotropic glutamate/pheromone receptors)
  • LY2140023
CXCL1 and MMP9 C-X-C motif chemokine ligand 1 matrix metallopeptidase 9
  • Chemokine receptors bind chemokines
  • G alpha (i) signalling events
  • Interleukin-10 signaling
  • Neutrophil degranulation
  • Signaling by SCF-KIT
  • Collagen degradation
  • Collagen degradation
  • Degradation of the extracellular matrix
  • Degradation of the extracellular matrix
  • Activation of Matrix Metalloproteinases
  • Assembly of collagen fibrils and other multimeric structures
  • EPH-ephrin mediated repulsion of cells
  • Interleukin-4 and Interleukin-13 signaling
  • Neutrophil degranulation
  • Extra-nuclear estrogen signaling
  • Glutathione
  • Marimastat
  • Minocycline
  • Captopril
  • Glucosamine
  • Zinc
  • 2-Amino-N,3,3-Trimethylbutanamide
  • 2-{[Formyl(Hydroxy)Amino]Methyl}-4-Methylpentanoic Acid
  • AE-941
  • PG-530742
  • 5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE
  • (2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE
  • (3R)-4,4-DIFLUORO-3-[(4-METHOXYPHENYL)SULFONYL]BUTANOIC ACID
  • Penile cancer
  • Metaphyseal dysplasias, including: Metaphyseal dysplasia, Schmid type; Metaphyseal dysplasia, McKusik type; Metaphyseal dysplasia, Jansen type; Shwachman-Bodian-Diamond syndrome (SBDS); Metaphyseal anadysplasia (MAD)
GSK3B and MITF glycogen synthase kinase 3 beta melanocyte inducing transcription factor
  • Degradation of beta-catenin by the destruction complex
  • Beta-catenin phosphorylation cascade
  • AKT phosphorylates targets in the cytosol
  • Regulation of HSF1-mediated heat shock response
  • CRMPs in Sema3A signaling
  • Disassembly of the destruction complex and recruitment of AXIN to the membrane
  • Disassembly of the destruction complex and recruitment of AXIN to the membrane
  • B-WICH complex positively regulates rRNA expression
  • Misspliced GSK3beta mutants stabilize beta-catenin
  • S33 mutants of beta-catenin aren't phosphorylated
  • S37 mutants of beta-catenin aren't phosphorylated
  • S45 mutants of beta-catenin aren't phosphorylated
  • T41 mutants of beta-catenin aren't phosphorylated
  • APC truncation mutants have impaired AXIN binding
  • AXIN missense mutants destabilize the destruction complex
  • Truncations of AMER1 destabilize the destruction complex
  • Degradation of GLI2 by the proteasome
  • GLI3 is processed to GLI3R by the proteasome
  • Constitutive Signaling by AKT1 E17K in Cancer
  • Ubiquitin-dependent degradation of Cyclin D
  • Regulation of RUNX2 expression and activity
  • SUMOylation of transcription factors
  • Lithium
  • 3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione
  • SB-409513
  • N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea
  • Staurosporine
  • Indirubin-3'-Monoxime
  • (3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h)-Dione 3-Oxime
  • Alsterpaullone
  • Phosphoaminophosphonic Acid-Adenylate Ester
  • 2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole
  • 5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione
  • (7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one
  • N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
  • 5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine
  • 3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one
  • N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide
  • 4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE
  • ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE
  • (2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE
  • Ocular albinism; Ocular albinism, type I (OA1); Waardenburg syndrome, type II (WS2-OA)
  • Waardenburg syndrome (WS)
  • Malignant melanoma
GTF2B and DRAP1 general transcription factor IIB DR1 associated protein 1
  • HIV Transcription Initiation
  • RNA Polymerase II HIV Promoter Escape
  • Transcription of the HIV genome
  • RNA Polymerase II Pre-transcription Events
  • RNA polymerase II transcribes snRNA genes
  • RNA polymerase II transcribes snRNA genes
  • RNA Polymerase II Promoter Escape
  • RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
  • RNA Polymerase II Transcription Initiation
  • RNA Polymerase II Transcription Initiation And Promoter Clearance
  • Signaling by NODAL
  • Signaling by Activin

Page 24 out of 43 pages